Centro Regional Integrado de Oncologia | Fortaleza, Brazil

Research site

(Unclaimed)

Location

Rua Francisco Calaca, 1300, Álvaro Weyne, Fortaleza, Ceara, Brazil

Site insights

Top conditions

Top treatments

Capecitabine

Ipilimumab

Pembrolizumab

INCMGA00012

Pertuzumab

Platinum

Paclitaxel

Carboplatin

Lapatinib

Leuprolide Acetate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 9 total trials

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

The goal of this study is to evaluate the efficacy and safety of pembrolizumab combined with carboplatin and paclitaxel as first-line treatment in pa...

Active, not recruiting

Squamous Cell Carcinoma of Head and Neck

Drug: Pembrolizumab

Drug: Paclitaxel

Locations recently updated

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)

This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast ca...

Active, not recruiting

HER2 Positive Breast Cancer

Drug: Pertuzumab

Drug: Trastuzumab

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants...

Active, not recruiting

Melanoma

Renal Cell Carcinoma (RCC)

Drug: INCB 99280 with Ipilimumab

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

A Phase III, randomised, double-blind, placebo-controlled, multi-centre study to assess the efficacy of olaparib maintenance monotherapy in relapsed...

Active, not recruiting

Relapsed Ovarian Cancer

Following Complete or Partial Response to Platinum Based Chemotherapy

Drug: Placebo to match olaparib 300mg

Drug: Olaparib 300mg tablets

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer (OVELIA)

This is a phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 to suppress ovarian function in premenopausal women with HR+,...

Enrolling

Breast Cancer

Drug: Anastrozole Tablets

Drug: Tamoxifen

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer (POD1UM-304)

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metast...

Active, not recruiting

Metastatic Nonsquamous Non-Small Cell Lung Cancer

Metastatic Squamous Non-Small Cell Lung Cancer

Drug: nab-Paclitaxel

Drug: Paclitaxel